Surgical Spring Week 2006: Scientific Sessions: Monday

Scientific Sessions: Monday, April 24

Current Management of Sigmoid Diverticulitis—GS11
Pay-for-performance: What You Should Know—GS12
Venous Disease—GS13
Current Management of Soft Tissue Infections—GS14
Angioaccess—GS15
Excelsior Surgical Society/Edward D. Churchill Lecture—GS16
Accelerated Partial Breast Irradiation (APBI)—GS17
Diagnosis, Surveillance, and Treatment of Dysplasia in the Gastrointestinal Tract—GS18
Using Best Evidence to Improve the Outcomes of Your General Surgery Patients—GS19
Current Role of Sentinel Lymph Node Biopsy in Cancer—GS20
Diagnosis and Management of Rectal Cancer—GS21
Fundamentals of Hepatic Surgery for the General Surgeon—GS22
Highlights from the 2005 Clinical Congress Video-Education Sessions—VE01

Current Management of Sigmoid Diverticulitis—GS11
8:00–9:30 am
Moderator:
Deborah A. Nagle, MD, FACS, Philadelphia, PA
This session will address the standard of care, evaluation, and treatment of sigmoid diverticulitis and evolving areas of management.

The Science Behind our Management of Diverticulitis
Jan Rakinic, MD, FACS, Springfield, IL

Surgical Management of Diverticulitis - Is there a Gold Standard?
Richard P. Billingham, MD, FACS, Seattle, WA

Laparoscopic Surgery and Diverticulitis
Conor P. Delaney, MD, PhD, FACS, Cleveland, OH

Treatment Algorithm for Acute Diverticulitis in 2006
To be announced

Panel Discussion

Back to top

Pay-for-performance: What You Should Know—GS12
8:00–9:30 am
Moderator:
William A. Rough, MD, FACS, Mount Holly, NJ

Pay-for-performance (P4P) will be the most radical change in physician reimbursement since the relative value base system was introduced. This panel presentation will provide up to the minute information to the practicing surgeon that will allow him/her to understand the details of P4P and consider adjustments in his/her office to be successful under this new system. Quality indicators, measurement, and reporting will be discussed including ACS programs such as NSQIP. The interactive roles of Centers for Medicare and Medicaid Services, private insurers, surgeons, hospitals, and patients in P4P will also be explored with ample time for the audience to direct specific questions to the panel.

Panelists:
Frank G. Opelka, MD, FACS, River Ridge, LA
R. Scott Jones, MD, FACS, Charlottesville, VA
Trent Haywood, MD, JD, Baltimore, MD
Charles M. Cutler, MD, Blue Bell, PA
Sandy Praeger, Topeka, KS

Back to top

Venous Disease—GS13
8:00–9:30 am
Moderator:
Anthony J. Comerota, MD, FACS, Toledo, OH

Considerable advances have been made in the evaluation and treatment of patients with acute and chronic venous disease. This session will review current risk factor assessment, prophylaxis, pharmacotherapy, and intervention designed to appropriately reduce the onset of acute deep venous thromboembolism (DVT), manage those diagnosed with acute DVT, and reduce the morbidity of chronic venous disease.

The participant should be able to identify the patient at high risk for DVT, prescribe appropriate prophylaxis, understand current pharmacotherapy for acute DVT, integrate a strategy for thrombus removal for patients with acute DVT to reduce postthrombotic morbidity, and recognize treatment options for acute venous disease.

Hypercoagulable States, Molecular Markers and Proper Prophylaxis of VTE
Joseph A. Caprini, MD, FACS, Glenview, IL

Proper Anticoagulation and the Role of New Therapeutic Agents
Thomas W. Wakefield, MD, FACS, Ann Arbor, MI

A Strategy of Thrombus Removal (Lytic Therapy and Venous Thrombectomy) for Extensive DVT: Any Benefit?
Anthony J. Comerota, MD, FACS, Toledo, OH

Advances in the Evaluation and Management of Chronic Venous Insufficiency
Robert B. McLafferty, MD, FACS, Springfield, IL

Panel Discussion

Back to top

Current Management of Soft Tissue Infections—GS14
9:45–11:15 am
Moderator:
Donald E. Fry, MD, FACS, Chicago, IL

This session will discuss current information about the management of severe soft tissue infections that may be caused by different bacterial organisms.

Streptococcal Soft Tissue Infection
Donald E. Fry, MD, FACS, Chicago, IL

Serious Staphylococcal Soft Tissue Infections
Lena M. Napolitano, MD, FACS, Ann Arbor, MI

Polymicrobinal Soft Tissue Infection
Christopher R. McHenry, MD, FACS, Cleveland, OH

Panel Discussion

Back to top

Angioaccess—GS15
9:45–11:15 am
Moderator:
R. James Valentine, MD, FACS, Dallas, TX

Attendees can expect to learn current recommendations for patients requiring permanent access for hemodialysis, including: Dialysis Outcomes Quality Initiative criteria, preoperative evaluation, patency rates of standard access grafts, complex options for hemodialysis access, access graft surveillance, and endovascular and surgical options for failing access grafts.

Current Recommendations for Access Placement
Thomas S. Huber, MD, FACS, Gainesville, FL

Complex Options for Hemodialysis Access
Ingemar Davidson, MD, FACS, Dallas, TX

Surveillance and Treatment of Failing Access
Joseph L. Mills, MD, FACS, Tucson, AZ

Back to top

Excelsior Surgical Society/Edward D. Churchill Lecture—GS16
11:15 am–12:15 pm

This lecture is named for the Excelsior Surgical Society, a group of 80 medical officers who met for the first time in 1945 at the Excelsior Hotel, Rome, Italy. This lecture also honors Colonel Edward D. Churchill, a famous surgeon and consultant to the US Army in the World War II Italian Theater, who presented the first keynote address at this meeting.

Introduction of Dr. Malangoni
Thomas R. Russell, MD, FACS, Chicago, IL

Introduction of Dr. Anderson
Mark Alan Malangoni, MD, FACS, Cleveland, OH

Introduction of Dr. Grosfeld
Kathryn D. Anderson, MD, FACS, San Marino, CA

Pediatric Surgery: Heritage of an Evolving Surgical Specialty
Jay L. Grosfeld, MD, FACS, Indianapolis, IN

Back to top

Accelerated Partial Breast Irradiation (APBI)—GS17
1:30–3:00 pm
Moderator:
James A. Edney, MD, FACS, Omaha, NE

APBI is a potentially important new modality to deliver radiotherapy in conjunction with breast conserving surgery within an abbreviated time period as compared with traditional external beam radiation, which takes 6½ weeks. In this session the relative merits of the various approaches available to deliver APBI will be examined, including catheter-based partial breast brachytherapy, intracavitary brachytherapy (Mammosite), 3-dimensional conformal/external beam radiotherapy, and intraoperative radiotherapy (Intrabeam).

3D Conformal External Beam Radiotherapy-5 days
Julia R. White, MD, Menomonee Falls, WI

Intracavitary Brachytherapy (Mammosite)-5 days
Victor J. Zannis, MD, FACS, Phoenix, AZ

Intraoperative Radiotherapy (Intrabeam)-30 minutes
James A. Edney, MD, FACS, Omaha, NE

Radio Frequency Assisted Lumpectomy-30 minutes
V. Suzanne Klimberg, MD, FACS, Little Rock, AR

Panel Discussion

Back to top

Diagnosis, Surveillance, and Treatment of Dysplasia in the Gastrointestinal Tract—GS18
1:30–3:00 pm
Moderator:
Fabrizio Michelassi, MD, FACS, New York, NY

The attendees will be able to review the modalities for diagnosis and surveillance of dysplasia of preneoplastic conditions in the gastrointestinal tract. Presentations will focus on dysplasia in Barrett's esophagus, intraductal papillary mucinous neoplasms, ulcerative colitis and anal intraepithelial neoplasia. Modern strategies of operative treatment will be reviewed for each of the above conditions with special emphasis on functional outcomes.

Diagnosis, Surveillance, and Treatment of Dysplasia in Barrett's Esophagus
Jeffrey H. Peters, MD, FACS, Rochester, NY

Diagnosis, Surveillance, and Treatment of Dysplasia in Ulcerative Colitis
Scott A. Strong, MD, Cleveland, OH

Diagnosis, Surveillance, and Treatment of Anal Intraepithelial Neoplasia
Mark L. Welton, MD, FACS, Stanford, CA

Diagnosis, Surveillance, and Treatment of IPMN
Michael B. Farnell, MD, FACS, Rochester, MN

Back to top

Using Best Evidence to Improve the Outcomes of Your General Surgery Patients—GS19
1:30–3:00 pm
Moderator:
Thomas H. Cogbill, MD, FACS, La Crosse, WI

This timely topic will be explored from four different vantage points: (1) rural general surgery practice, (2) university teaching program, (3) multispecialty group practice experience with a new procedure, and (4) multispecialty group practice experience with an established procedure. Speakers will draw on their own unique perspectives to highlight the methods with which current best evidence has been incorporated into their practices to improve patient outcomes. These methods will be illustrated with specific examples from their recent experience.

How Best Evidence Affects a Truly Rural Surgeon
Marilu Bintz, MD, FACS, Prairie Du Chien, WI

Incorporating Best Evidence in an University Surgical Residency Program
Melanie L. Richards, MD, FACS, San Antonio, TX

Developing a New Surgical Product Line — The Bariatric Experience
Shanu N. Kothari, MD, FACS, La Crosse, WI

Redesigning an Existing Surgical Product Line Involving Multiple Specialties — The Carotid Endarterectomy Experience
Thomas H. Cogbill, MD, FACS, La Crosse, WI

Panel Discussion

Back to top

Current Role of Sentinel Lymph Node Biopsy in Cancer—GS20
3:30–5:00 pm
Moderator:
Marc K. Wallack, MD, FACS, New York, NY

This surgical forum will review the list of sentinel lymph node biopsy and then address its use in treating cancer of the breast and melanoma. Furthermore, there will be some mention of new horizons with this technique.

The History and Science of the Sentinel Node
Donald L. Morton, MD, FACS, Santa Monica, CA

Use of Sentinel Node in Breast Cancer
Charles E. Cox, MD, FACS, Tampa, FL

Use of Sentinel Node in Melanoma
William R. Jewell, MD, FACS, Kansas City, KS

Back to top

Diagnosis and Management of Rectal Cancer—GS21
3:30–5:00 pm
Moderator:
Victor E. Pricolo, MD, FACS, Providence, RI

The objective of this session is to provide an understanding of the current diagnostic and staging modalities for cancer of the rectum. Participants will be informed of treatment options including surgery, chemotherapy, and radiation therapy for various stages of curable rectal cancer.

Pretreatment Staging: Old and New Technologies
Madhulika G. Varma, MD, FACS, San Francisco, CA

Neo-adjuvant Therapy: New Agents and Protocols
Howard Safran, MD, Providence, RI

Local Excision — When Can We Get Away With It?
Martin R. Weiser, MD, FACS, New York, NY

Radical Resection — Can a Stoma Be Avoided?
Victor E. Pricolo, MD, FACS, Providence, RI

Panel Discussion

Back to top

Fundamentals of Hepatic Surgery for the General Surgeon—GS22
3:30–5:00 pm
Moderator:
Joseph B. Cofer, MD, FACS, Chattanooga, TN

This session will cover the workup of the solid liver mass and describe the identification and treatment of benign liver lesions together with primary and metastatic liver lesions. In addition, this session will describe how to diagnose and treat common biliary tract injury, how to diagnose and treat primary hepatocellular cancer, when resection is indicated, and when to refer for transplantation. Finally, this session will discuss novel means of therapy.

Evaluation of the Incidental Liver Mass
Reid B. Adams, MD, FACS, Charlottesville, VA

Surgery for Benign Liver Disease
Joseph B. Cofer, MD, FACS, Chattanooga, TN

Primary Malignant Liver Disease
William C. Chapman, MD, FACS, St. Louis, MO

Metastatic Malignant Liver Disease
Ravi S. Chari, MD, FACS, Nashville, TN

Back to top

Highlights from the 2005 Clinical Congress Video-Education Sessions—VE01
7:00–9:30 pm
Moderator:
Daniel B. Jones, MD, FACS, Boston, MA

Videotaped surgical procedures performed and narrated by general surgeons will be presented during this evening session. An interactive panel discussion will encourage participants to present questions or challenges to the coordinator and guest panelists. These videos were previously shown at the 2005 Clinical Congress.

Panelists:
Michel Gagner, MD, FACS, New York, NY
John H. Marks, MD, FACS, Wynnewood, PA
David A. Provost, Jr., MD, FACS, Dallas, TX
John F. Sweeney, MD, FACS, Houston, TX

Laparoscopic Resection of Splenic Cyst
Sergey Lyass, MD, Los Angeles, CA
Edward H. Phillips, MD, FACS, Los Angeles, CA
Miguel A. Burch, MD, Los Angeles, CA

Video-Assisted Thyroidectomy with Intraoperative Nerve Monitoring
Celestino P. Lombardi, MD, Rome, Italy
Marco Raffealli, MD, Rome, Italy
Mauro Boscherini, MD, Rome, Italy
Luca Revelli, MD, Rome, Italy
Anna Maria D'Amore, Rome, Italy
Rocco Bellantone, MD, Rome, Italy

Thoraco-laparoscopic Esophagectomy for Carcinoma Esophagus Middle Third
Chinnusamy Palanivelu, MB, BS, FACS, Coinbatore, India

Laparoscopic Total Gastrectomy with D3 Lymphadenectomy
Cristiano G.S. Huscher, MD, FACS, Rome, Italy
M. Di Paola, MD, Rome, Italy
C. Ponzano, MD, Rome, Italy
A. Recher, MD, Rome, Italy
A. Sansonetti, MD, Rome, Italy
Andrea Mingoli, MD, FACS, Rome, Italy

Laparoscopic Live Donor Nephrectomy
Amit Basu, MBBS, FACS, Pittsburgh, PA
Ron Shapiro, MD, FACS, Pittsburgh, PA
Akhtar S. Khan, MD, Pittsburgh, PA
Amadeo Marcos, MD, Pittsburgh, PA
Henkie P. Tan, MD, FACS, Pittsburgh, PA

Laparoscopic Left Colectomy for Treatment of Diverticular Abscess
John H. Marks, MD, FACS, Wynnewood, PA
R.K. Annamaneni, MD, Wynnewood, PA
T. Curran, BA, Wynnewood, PA
Gerald Marks, MD, FACS, Wynnewood, PA

Laparoscopic Total Proctocolectomy with End Ileostomy for Crohn's Disease
Alessandro Fichera, MD, Chicago, IL
Roger D. Hurst, MD, FACS, Chicago, IL

Minimally Invasive Robotic Assisted Middle Segment Pancreatectomy
Pier C. Giulianotti, MD, Grosseto, Italy
Fabio Sbrana, MD, Grosseto, Italy
Giuseppe Caravaglios, MD, Grosseto, Italy
Marta Angelini, MD, Grosseto, Italy
Andrea Coratti, MD, Grosseto, Italy
Edoardo Gentile, MD, Grosseto, Italy
Luca Felicioni, MD, Grosseto, Italy

The World's First Totally Robotic, Laparoscopic Roux-en-Y Gastric Bypass
Geoffrey S. Nadzam, MD, New Haven, CT
Myriam J. Curet, MD, FACS, Palo Alto, CA
Catherine J. Mohr, MSME, Palo Alto, CA

Band Erosion and Severe Bleeding in a Pregnant Patient
Michael Baptista, MD, Chicago, IL
Veronica Gorodner, MD, Chicago, IL
Carlos A. Galvani, MD, Chicago, IL
Stanley Horky, MD, Chicago, IL
Santiago Horgan, MD, Chicago, IL

When the Lap Band Fails: Laparoscopic Conversion from Lap Band to Biliopancreatic
Diversion with Duodenal Switch
Brian P. Jacob, MD, New York, NY
William B. Inabnet, MD, FACS, New York, NY

Laparoscopic Jejunal Sleeve: A New Technique for Revision of Roux-en-Y Bypass after Weight Regain
Vivian E. Strong, MD, New York, NY
Michel Gagner, MD, FACS, New York, NY

Back to top